Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).
about
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesGender analysis of moxifloxacin clinical trialsClinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial.Role of antimicrobial agents in the management of exacerbations of COPD.Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.Treating acute exacerbations of chronic bronchitis and community-acquired pneumonia: how effective are respiratory fluoroquinolones?Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysisThe diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis.Short-course fluoroquinolones in acute exacerbations of chronic bronchitis.Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis.
P2860
Q28243911-25BD2732-66E8-4F66-90C0-E65A75B81319Q28538319-B6A20865-7453-4E7E-BAC0-8A5D1752C5D2Q34706478-E2EBC3B8-1B83-4D67-B69E-E5B0D635C4AEQ36178733-455DA26F-0EDD-4755-B2B2-6EDA2EBBE3B1Q36213054-0745EEB4-20AD-42B7-8B73-FAAC66D9AFCEQ36728602-CFD3BA43-9ED9-4C62-A30A-394F6261DB0AQ37071001-5D9B6649-DFE2-419C-8404-C324D73137D0Q37629535-CD19D402-56ED-4B74-B3F0-C0D2EA64531EQ37732428-F940F38F-8EF6-43AA-8390-8D88219918DBQ37798032-170C58A5-7D59-4893-9491-EEF5771EDBFBQ39340230-C04A198C-1EF4-4746-AF05-C8C79336B4B1Q40448715-F2B3BE3C-5945-457E-8DA0-E6718CF24DE1Q41405351-4CC2A9E4-394E-4FA2-A254-3260CCD33B81
P2860
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB).
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Efficacy and safety of short c ...... of chronic bronchitis (AECB).
@en
Efficacy and safety of short course
@nl
type
label
Efficacy and safety of short c ...... of chronic bronchitis (AECB).
@en
Efficacy and safety of short course
@nl
prefLabel
Efficacy and safety of short c ...... of chronic bronchitis (AECB).
@en
Efficacy and safety of short course
@nl
P2093
P2860
P1476
Efficacy and safety of short c ...... of chronic bronchitis (AECB).
@en
P2093
M Tellarini
SMART Study Group. Studio Mult ...... izzazioni de Bronchite Cronica
P2860
P304
P356
10.1179/JOC.2002.14.6.597
P577
2002-12-01T00:00:00Z